An advisory committee faces a range of bewildering scientific questions surrounding whether to authorize additional coronavirus vaccine doses, and for whom.
Published: September 17, 2021 at 02:06PM
from NYT Health https://ift.tt/2Zb8dKd
An advisory committee faces a range of bewildering scientific questions surrounding whether to authorize additional coronavirus vaccine doses, and for whom.
Published: September 17, 2021 at 02:06PM
from NYT Health https://ift.tt/2Zb8dKd